UnknownNot Applicable

Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular Lenses

176 participantsStarted 2019-10-14

Plain-language summary

A prospective randomized controlled clinical study to measure posterior capsular opacification, objective measurement of glistenings and intraocular lens tilt and decentration as well as visual outcomes following insertion of a monofocal, aspheric, hydrophobic acrylic intraocular lens: the RayOne® Hydrophobic lens 800C and a monofocal aspheric, hydrophilic acrylic intraocular lens: the RayOne® Hydrophilic lens 600C

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Unilateral or bilateral cataracts requiring surgical intervention
✓. Age over 18 years
✓. Able to understand informed consent and the objectives of the trial
✓. Not pregnant, not breast feeding
✓. No previous eye surgery
✓. Corneal astigmatism less than 1 diopter in both eyes.

Exclusion criteria

✕. age-related macula degeneration
✕. glaucoma
✕. previous retinal vascular disorders
✕. previous retinal detachment or tear
✕. any neuro-ophthalmological condition
✕. any inherited retinal disorder or pathology
✕. previous strabismus surgery or record of amblyopia
✕. previous TIA, CVA or other vaso-occlusive disease

What they're measuring

Posterior Capsular Opacification of Intraocular Lens

Timeframe: 24 months

Intraocular lens glistenings

Timeframe: 24 months

Intraocular lens tilt and decentration

Timeframe: 24 months

Trial details

NCT IDNCT04122664

SponsorGuy's and St Thomas' NHS Foundation Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05

Contact for this trial

Khayam Naderi, MBBS BSc MA

020 7188 7188 khayam.naderi@gstt.nhs.uk

View on ClinicalTrials.gov More Cataract trials